Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4317-4322

  Halder, Chandralekha ^a   Ossendorf, Christian ^b   Maran, Avudaiappan ^a   Yaszemski, Michael ^a   Bolander, Mark E ^a   Fuchs, Bruno ^b   Sarkar, Gobinda ^a  

^a MAYO CLINIC   (United States)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Alternative splicing; Metastasis; Osteosarcoma; PCR; TEM7

Indexed keywords

MESSENGER RNA; TUMOR ENDOTHELIAL MARKER 7; TUMOR MARKER; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE NEOPLASMS; CELL LINE, TUMOR; HUMANS; NEOPLASM PROTEINS; OSTEOSARCOMA; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 75149178656     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fuchs B, Mahlum E, Halder C, Maran A, Yaszemski M, Bode B, Bolander M and Sarkar G: High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 399: 137-143, 2007.
2. Husmann K, Muff R, Bolander ME, Sarkar G, Born W, Fuchs and B: Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog 47: 66-73, 2008.
3. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P and Helman L: Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 3750-3759, 2001.
4. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186, 2004.
5. Kim MS, Song WS, Cho WH, Lee SY and Jeon DG: Ezrin expression predicts survival in stage HB osteosarcomas. Clin Orthop Relat Res 459: 229-236, 2007.
6. Srivastava A, Fuchs B, Zhang K, Ruan M, Halder C, Mahlum E, Weber K, Bolander ME and Sarkar G: High WTl expression is associated with very poor survival of patients with. osteogenic sarcoma metastasis. Clin Cancer Res 12: 4237-4243, 2006.
7. St Croix CB, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW: Genes expressed in human tumor endothelium. Science 289: 1197-1202, 2000.
8. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW and St Croix C B: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61: 6649-6655, 2001.
9. Lee HK, Bae HR, Park HK, Seo IA, Lee EY, Suh DJ and Park HT: Cloning, characterization and neuronal expression profiles of tumor endothelial marker 7 in the rat brain. Mol Brain Res 136: 189-198, 2005.
10. Nanda A, Buckhaults P, Seaman S, Agrawal N, Boutin P, Shankara S, Nacht M,Teicher B, Stampfl J, Singh S, Vogelstein B, Kinzler KW and St Croix CB: Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res 64: 8507-8511, 2004.
11. Yuan J, Ossendorf C, Szatkowski JP, Bronk JT, Maran A, Yaszemski M, Bolander ME, Sarkar G and Fuchs B: Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest 27: 435-442, 2009.